When the front of the eye is injured or inflamed, healing can stall in ways that feel disproportionate to the original problem—persistent pain, light sensitivity, blurred vision, and a surface that simply will not “seal.” Amniotic membrane therapy is one of the most practical tools eye specialists use to restart that healing process. It works like a biologic bandage: it protects the cornea, supports new epithelial growth, and helps calm inflammatory signaling on the ocular surface. In many cases, it also reduces discomfort quickly, which matters when blinking becomes painful.
Amniotic membrane is not a first-step treatment for routine dryness or minor scratches. It is typically reserved for eyes at risk of slow healing, scarring, or surface breakdown. Understanding when it’s used, what placement is like, and what recovery tends to look like can turn an intimidating recommendation into a clear plan you can follow with confidence.
Quick Overview
- Amniotic membrane can accelerate epithelial healing and reduce surface inflammation when standard therapies are not enough.
- Many patients notice meaningful pain relief within 24–72 hours, even before vision fully clears.
- Infection, severe dryness, and eyelid inflammation must be managed in parallel, or the membrane may not deliver lasting benefit.
- Typical wear time for a self-retained device is often about 3–7 days, followed by a recheck and possible replacement if needed.
Table of Contents
- What amniotic membrane does
- Conditions it is used for
- Types and placement methods
- What the procedure feels like
- Recovery timeline and follow-up
- Aftercare, drops, and activity limits
- Risks, results, and alternatives
What amniotic membrane does
Amniotic membrane is the thin inner lining of the placenta. In eye care, it is processed and preserved so it can be used as a sterile, biologic dressing for the ocular surface. It is not the same as a standard contact lens. A contact lens mostly shields the surface mechanically. Amniotic membrane provides both protection and a biologically active scaffold that can change the healing environment.
How it helps the cornea heal
The cornea’s outer layer (epithelium) normally repairs quickly. But when the surface is inflamed, dry, poorly innervated, or repeatedly traumatized, epithelial cells may not adhere well. Amniotic membrane can help by:
- Acting as a scaffold: it gives migrating epithelial cells a friendlier surface to grow across and attach to.
- Calming the inflammatory loop: ocular surface inflammation can become self-perpetuating. The membrane can dampen inflammatory signaling and reduce the “hot” environment that blocks healing.
- Reducing friction: blinking over a damaged surface is like rubbing a healing wound. The membrane forms a smoother interface.
- Supporting nerve and surface recovery: many patients feel less pain as the surface stabilizes, and some conditions improve as the cornea becomes less irritated and more resilient.
Why it can reduce pain quickly
Pain relief is often one of the earliest benefits. A compromised cornea exposes sensitive nerve endings and becomes hypersensitive to light and wind. By covering the injured area, the membrane reduces exposure and irritation. This can make it easier to open the eye, tolerate drops, and sleep—small wins that also support healing.
What it does not do
Amniotic membrane is not a cure by itself if the drivers of poor healing remain unaddressed. For example:
- If the eye is too dry, the surface may break down again after the membrane dissolves or is removed.
- If there is active infection, antimicrobial treatment still matters, and some infections need close monitoring.
- If eyelids are inflamed or not closing well, the cornea may remain mechanically stressed.
The best outcomes happen when the membrane is used as part of a complete plan—surface protection plus targeted treatment of the cause.
Conditions it is used for
Amniotic membrane is typically used when an eye is at risk of delayed healing, scarring, or surface breakdown. Eye clinicians recommend it when the expected benefit is not only faster closure of a defect, but also a healthier, quieter ocular surface afterward.
Persistent epithelial defects and slow-healing abrasions
A persistent epithelial defect is a corneal surface wound that does not close as expected. Reasons include severe dryness, diabetes, medication toxicity, eyelid disease, exposure (incomplete lid closure), or poor corneal sensation. In these cases, the membrane can provide a protected setting for cells to migrate and adhere. It is often considered when frequent lubricants, therapeutic contact lenses, and supportive drops have not led to steady progress.
Neurotrophic keratitis
When corneal nerves are impaired, the eye may not feel pain normally, blinking may be less protective, and epithelial repair can be weak. The membrane is commonly used to stabilize the surface and reduce the risk of deeper ulcers. Neurotrophic keratitis often requires layered therapy, and the membrane may be one step among others to prevent a small defect from becoming a major injury.
Chemical burns and acute inflammatory surface injury
For chemical injuries and severe surface inflammation, timing matters. Early surface coverage can reduce ongoing inflammation, limit scarring, and preserve a smoother ocular surface for later recovery. In these scenarios, amniotic membrane may be placed in the operating room or applied as a sutureless device, depending on severity.
Severe dry eye and ocular surface inflammation
In advanced dry eye, the cornea can develop staining, erosions, filamentary keratitis, and pain that does not respond well to routine drops. Amniotic membrane may be used as a “reset,” providing temporary biologic protection while long-term therapies (anti-inflammatory drops, lid treatments, moisture strategies) begin to work.
Post-surgical and trauma-related surface problems
After certain surgeries or injuries, the surface may remain rough, painful, or slow to re-epithelialize. In some cases, the membrane is used to speed closure, reduce haze risk, or decrease discomfort while tissues stabilize.
A key theme across these indications is risk: when the surface is unlikely to heal smoothly on its own, the membrane is used to prevent a prolonged course and to reduce the chance that a temporary defect becomes a permanent scar.
Types and placement methods
Amniotic membrane can be delivered in different ways, and the method often predicts what recovery feels like. Your clinician’s choice depends on the size and depth of the defect, how inflamed the eye is, and whether the goal is surface coverage, structural support, or both.
Cryopreserved versus dehydrated
You may hear about cryopreserved and dehydrated (or “dried”) membrane.
- Cryopreserved membrane is stored cold and tends to be used when clinicians want robust biologic activity along with coverage.
- Dehydrated membrane is shelf-stable and can be convenient in some settings, though handling, rehydration, and clinical preferences vary.
Both types are used in practice. Your clinician will choose based on the problem being treated, availability, and experience.
Overlay, inlay, and multilayer techniques
The membrane can be placed:
- As an overlay (patch): laid on top of the surface like a biologic dressing. This is common for epithelial defects, inflammation, and pain control.
- As an inlay (graft): tucked into a defect to fill or support tissue, sometimes when there is stromal involvement.
- In multiple layers: stacked when more structural fill is needed, such as deeper ulcers or small perforation risk scenarios.
These choices affect vision temporarily. Overlay methods may blur vision mildly. Multilayer approaches can blur more until healing progresses.
Sutured, glued, or self-retained devices
Placement typically falls into two broad categories:
- In-office, self-retained placement
A ring-supported device can be inserted without sutures, similar to placing a large contact lens. It is commonly used for moderate surface disease, persistent epithelial defects, and severe dry eye flares when outpatient treatment is appropriate. - Operating room placement with sutures or tissue adhesive
Sutured or glued membrane may be used when coverage must be very secure, when the eye is extremely inflamed, or when more complex reconstruction is needed.
How long it stays in place
Some membranes gradually dissolve; others are removed after the eye stabilizes. A self-retained device is often left in for several days, then removed or replaced based on healing progress. If a defect is stubborn, repeating the placement can be part of the plan rather than a sign that it “failed.”
It can help to ask one specific question before placement: Is the goal mainly to heal the surface, to reduce inflammation and pain, or to add structural support? The answer clarifies why your clinician chose a particular membrane type and technique.
What the procedure feels like
Most patients feel better knowing what the first day is actually like. The experience varies by method, but the overall pattern is predictable: the placement itself is brief, the eye may feel “full” afterward, and vision is often temporarily blurrier while the membrane does its work.
Before placement
Your clinician typically checks the cornea under magnification and may measure the defect size, surface staining, and lid closure quality. You may receive anesthetic drops. If infection is suspected, the plan may include antimicrobial drops first, with membrane placement after the infection is controlled or at the same visit when the clinician believes coverage is safe.
If you are having in-office placement, you will usually be advised to avoid eye makeup and to bring sunglasses. If you wear contact lenses, you will be asked to stop lens wear.
During placement
For a self-retained device, anesthetic drops reduce discomfort. You may feel pressure as the membrane ring is positioned under the eyelids. The sensation is more “foreign body” than sharp pain. The procedure is typically measured in minutes.
For sutured placement, you may receive a local anesthetic injection and, depending on complexity, sedation. Afterward, the eye is often patched briefly or protected with a shield.
After placement: common sensations
It is normal to experience:
- Blurred vision: the membrane is not optically clear in the way a contact lens is. Some people describe looking through wax paper or fog.
- A bulky or scratchy feeling: especially with ring-supported devices, because the eyelids can feel the ring edges.
- Tearing and mild light sensitivity: usually improves as the surface calms.
- Reduced pain over time: many patients notice pain relief within the first few days, even if vision remains blurry.
If discomfort is severe or worsening rather than stabilizing, the device may be displaced, folded, or rubbing in a way that needs adjustment.
What is not normal
Call your clinician promptly if you develop:
- Rapidly increasing pain, especially deep aching pain
- Significant worsening redness or swelling
- Thick discharge
- New dramatic light sensitivity
- Sudden drop in vision beyond expected blur
These can signal infection, inflammation inside the eye, or mechanical issues requiring immediate evaluation.
A useful expectation is this: the membrane may feel annoying, but it should not feel dangerous. If your instinct is that something is wrong, that is worth checking quickly.
Recovery timeline and follow-up
Recovery is best understood as two overlapping timelines: the membrane’s “active treatment window” (while it is on the eye) and the ocular surface’s “stabilization window” (after it’s removed or dissolves). The first is often days; the second may be weeks.
First 24 hours
- Vision is typically blurry on the treated eye.
- Foreign body sensation and tearing are common.
- Many people notice the eye feels more protected, even if it still feels gritty.
If you were in significant pain before treatment, your clinician may check you sooner, particularly if the cornea was very compromised.
Days 2 to 4
This is often when people notice the most meaningful symptom shift:
- Pain and burning may decrease.
- Light sensitivity often becomes more manageable.
- The surface may look less inflamed on examination.
If a self-retained device is used, this is also the period when the ring can feel most noticeable. Lubrication and careful drop technique can help.
Days 4 to 7
Many clinicians recheck during this window to assess defect closure and decide whether to remove, replace, or continue protection.
Possible outcomes include:
- Defect closed: the membrane is removed or allowed to finish dissolving, and a stabilization plan follows.
- Defect improved but not closed: the membrane may be replaced or a different strategy added (for example, stronger dryness control or addressing lid closure).
- Minimal improvement: prompts a deeper look at why healing is stalled, such as ongoing exposure, medication toxicity, infection, or neurotrophic issues.
Weeks 2 to 6
This is the stabilization phase, where the goal is to prevent recurrence and restore comfort and clarity.
- Vision often clears gradually as the epithelium smooths.
- Some patients have fluctuating blur from surface dryness even after the defect closes.
- Underlying drivers—dry eye, eyelid disease, exposure, systemic conditions—must be actively managed.
When recovery takes longer
Longer timelines are more common when the initial problem was severe (chemical burns, advanced neurotrophic keratitis), when the eye has poor sensation, or when dryness is extreme. In these situations, clinicians may use repeat membrane placement, combine therapies, or escalate to more specialized interventions.
A helpful mindset is to measure progress in trend lines rather than daily fluctuations. Your clinician is looking for steady reduction in staining, improved epithelial integrity, and decreasing inflammation—not perfection overnight.
Aftercare, drops, and activity limits
Aftercare varies by diagnosis and placement method, but the principles are consistent: protect the membrane, prevent infection when risk is present, and reduce surface stress while the epithelium strengthens.
Typical drop routines
Your clinician may prescribe a combination of:
- Lubrication: preservative-free artificial tears are often used multiple times daily to reduce friction and improve comfort.
- Antibiotic drops: commonly used when there is an epithelial defect or infection risk.
- Anti-inflammatory drops: sometimes used to reduce surface inflammation, but the timing and choice depend on whether infection is a concern.
- Specialty surface-healing drops: in certain cases, additional therapies are used to support epithelial health.
Follow the exact schedule you’re given. If you are using multiple drops, a practical spacing rule is to separate them by at least 5 minutes so each medication has time to coat the surface.
Physical protection
- Use a protective shield at night if recommended, especially if you rub your eyes in your sleep.
- Avoid rubbing the eye during the treatment window. Rubbing can dislodge a membrane or worsen surface injury.
- Sunglasses can reduce light sensitivity and wind irritation.
Activity guidance
Many people can work and do routine activities, but plan around temporary vision blur:
- Avoid driving if your vision is not safe, especially at night.
- Be cautious with dusty environments, smoke, and strong airflow.
- Avoid swimming and hot tubs during the active healing phase unless your clinician says otherwise.
If you have a ring-supported device, some clinicians recommend avoiding vigorous exercise that increases sweat and eye rubbing risk during the first few days.
How to handle discomfort safely
If discomfort flares:
- Increase lubrication as allowed.
- Use cool compresses if approved.
- Ask your clinician before using any over-the-counter redness relievers, which can worsen surface dryness.
Pain that steadily worsens is not something to “push through.” The goal is controlled healing, not endurance.
Follow-up matters as much as placement
Amniotic membrane works best with timely rechecks. If you miss the window when the clinician needs to assess closure, you can lose momentum: a healed surface can break down again if the underlying stressor is still present. Keep follow-up appointments even if you feel better.
Risks, results, and alternatives
Amniotic membrane is widely used because the benefit-to-risk balance is favorable in the right patient. Still, it is important to understand what can go wrong, what success looks like, and what options exist if you do not improve as expected.
Expected results
Success is usually defined by a combination of:
- Closure of the epithelial defect
- Reduced staining and surface inflammation
- Less pain and light sensitivity
- A smoother corneal surface over time, which supports clearer vision
In many cases, symptom relief begins before the cornea looks fully normal. Vision may lag because the surface needs time to remodel and because dryness can persist.
Common downsides and manageable issues
- Temporary blurred vision: very common during treatment.
- Foreign body sensation: especially with self-retained devices.
- Device displacement: can happen if the eye is rubbed or the eyelids are tight; it may need repositioning or replacement.
- Recurrence of the defect: if dryness, exposure, or neurotrophic issues are not addressed, the surface can break down again.
Less common but important risks
- Infection: any time the corneal surface is compromised, infection risk rises. This is why clinicians often pair membrane use with antimicrobial strategies when appropriate.
- Inflammatory flare: uncommon, but worsening redness, pain, and light sensitivity need assessment.
- Delayed healing due to the underlying cause: the membrane is not a substitute for correcting exposure, treating lid disease, or improving ocular surface environment.
How it compares with other options
Depending on the situation, alternatives or companion therapies may include:
- Bandage contact lens: helpful for protection, but less biologically active than amniotic membrane.
- Serum-based tears or similar biologic drops: can support healing in stubborn surface disease, often used alongside other strategies.
- Treatments for neurotrophic disease: used when nerve dysfunction is the main barrier to healing.
- Tarsorrhaphy or lid management: considered when incomplete lid closure or exposure is driving breakdown.
- Corneal procedures: in severe scarring, thinning, or perforation risk, more advanced interventions may be needed.
A practical decision guide is to ask: Are we trying to heal a defect, reduce inflammation, restore surface stability, or all three? The best therapy is the one that matches the dominant problem, not just the most advanced-sounding option.
References
- A Narrative Review of Amniotic Membrane Transplantation in Ocular Surface Repair: Unveiling the Immunoregulatory Pathways for Timely Intervention 2025 (Review)
- Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications 2024 (Review)
- Amniotic membrane graft (AMG) for persistent epithelial defects following infective corneal ulcers and keratitis – A systematic review 2024 (Systematic Review)
- Self-Retained, Sutureless Amniotic Membrane Transplantation for the Management of Ocular Surface Diseases 2023 (Clinical Review)
Disclaimer
This article is for educational purposes and does not provide medical advice or a diagnosis. Amniotic membrane therapy can support ocular surface healing in selected conditions, but the correct treatment plan depends on the cause, severity, and infection risk. Seek urgent eye care for severe or worsening pain, increasing light sensitivity, thick discharge, rapidly worsening redness, new flashes or floaters, or any sudden decrease in vision. If you have been advised to undergo amniotic membrane placement, follow your clinician’s instructions closely and attend all scheduled follow-up visits, since timely reassessment is essential to confirm healing and prevent recurrence.
If you found this article helpful, please consider sharing it on Facebook, X (formerly Twitter), or any platform you prefer.
